You are here

Meeting Highlights

American Society of Hematology State-of-the-Art Symposium: Myeloma and Lymphoma: Recent Advances in Biology and Therapy

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Progress is being made in the way tumors are being targeted by agents such as lenalidomide, bortezomib, rituximab, and a variety of other novel chemotherapeutic regimens.